Table 2:

Progression to pneumonia and treatment administered.

	Total n=197	Mild n=127	Critical n=70
Pneumonia, n (%)	165 (83.8)	106 (83.5)	59 (84.3)
CURB-65=0	31 (18.8)	26 (24.6)	5 (8.5)
CURB-65=1	44 (26.7)	34 (32.0)	10 (17.0)
CURB-65=2	68 (41.2)	37 (34.9)	31 (52.5)
CURB-65=3	22 (13.3)	9 (8.5)	13 (22.0)
Treatment, n (%)
Hydroxychloroquine	161 (81.7)	110 (86.6)	51 (72.9)
Lopinavir/Ritonavir	94 (47.7)	62 (48.8)	32 (45.7)
Corticosteroids	58 (29.4)	24 (18.9)	34 (48.6)
Azithromycin	27 (13.7)	7 (5.5)	20 (28.6)
Tocilizumab	12 (6.1)	0 (0.0)	12 (17.1)
Interferon β	10 (5.1)	5 (3.9)	5 (7.1)
Ciclosporin	4 (2.0)	3 (2.4)	1 (1.4)
Anakinra	3 (1.5)	1 (0.8)	2 (2.9)